Skip to main content
Toggle navigation
Login
Search
Home
Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
H
Hai, Min
The Ohio State University
(
T-053
)
Modeling and inter-species scaling of plasma DHO as a biomarker to inform first-in-human dose selection for a novel DHODH inhibitor
Min Hai
Favorite
Hajjawi, Malek
Indiana University School of Medicine
(
W-038
)
Development of a Physiologically-Based Pharmacokinetic (PBPK) Model for Caffeine in Pregnancy: Evaluating Neonatal Transfer
Malek Hajjawi
Favorite
(
W-039
)
Predictive Pharmacokinetic Analysis of Novel PLCG2 Inhibitors Using GastroPlus and ADMET Predictor
Malek Hajjawi
Favorite
Hamada, Izumi
Bristol Myers Squibb
(
M-040
)
Novel endpoints based on tumor growth dynamics – A comprehensive simulation study with retrospective validation
Izumi Hamada
Favorite
Hasegawa, Chihiro
Merck Sharp & Dohme
(
M-041
)
Exploring Best Practices of the Population Pharmacokinetic Modeling for Antibody-Drug Conjugates – a Simulation Study
Chihiro Hasegawa
Favorite
(
M-042
)
Model-Informed Dose Justifications and Clinical Pharmacology Strategy of Posaconazole in Japanese Patients for Prophylaxis and Treatment Against Fungal Infection
Chihiro Hasegawa
Favorite
Heathman, Michael
Metrum Research Group
(
T-054
)
The effect of CYP2B6 genotype on the clearance and autoinduction of efavirenz in healthy subjects and the subsequent impact on efavirenz exposure.
Michael Heathman
Favorite
Hennion, Maud
Cencora Pharmalex
(
T-055
)
Population PK model on preclinical data for optimization of further clinical trial designs in oncology
Maud Hennion
Favorite
Henscheid, Nick
Critical Path Institute
(
W-040
)
Extracting Lab Value Reference Ranges from Neonatal Real-World Data in OMOP Format
Nick Henscheid
Favorite
Her, Lucy
Eli Lilly
(
M-043
)
Image Processing with Spatial Modeling of Neural Tissue: A New Approach to Pharmacokinetic Analysis
Lucy Her
Favorite
Herrera Reyes, Alejandra Donaji
Merck & Co., Inc., Rahway, NJ, USA
(
W-041
)
Inferring HIV rebound timing from a noisy biomarker
Alejandra Donaji Herrera Reyes
Favorite
Herron, Cody
Pfizer
(
M-044
)
MIDD Platform of VZV Vaccine Immunogenicity and Efficacy
Cody Herron
Favorite
He, Yanna
IMPACT Therapeutics, Inc. (Shanghai)
(
W-132
)
Population Pharmacokinetic Modeling of IMP7068 in Patients with Advanced Solid Tumors
Yanna He
Favorite
Hooker, Andrew
Uppsala University
(
T-056
)
A modified Bayesian information criterion (mBIC) with multiple testing correction for population pharmacokinetic model building
Andrew Hooker
Favorite
Hosawi, Anhar
University of Cincinnati / Cincinnati Children's Hospital Medical Center
(
W-042
)
Population Pharmacokinetic Modeling of Hydroxyurea in Plasma and Breast Milk in Lactating Women
Anhar Hosawi
Favorite
Huang, Hannah
Arcus Biosciences
(
W-045
)
Clinical Trial Simulation to Assess Sample Size and Power For Detecting Differences in Pharmacokinetic Exposure Metrics
Hannah Huang
Favorite
Huang, Weize
Genentech
(
M-046
)
Development and Application of Inavolisib Physiologically-based Pharmacokinetic (PBPK) Model for Drug-drug Interaction (DDI) Assessment
Weize Huang
Favorite
Huang, Yunda
Fred Hutchinson Cancer Center
(
W-140
)
Pharmacokinetics Analysis of Serum and Rectal Tissue Concentrations of VRC01 and VRC01LS in People Without HIV in a Phase 1 Clinical Trial (HVTN 116)
Yunda Huang
Favorite
Hu, Chuanpu
Bristol Myers Squibb
(
M-045
)
Visual predictive check of longitudinal models and dropout
Chuanpu Hu
Favorite
Hudson, Rachel
Bristol Myers Squibb
(
M-047
)
Population Pharmacokinetics of Nivolumab in Patients with Newly Diagnosed or Relapsed/Refractory Classical Hodgkin Lymphoma
Rachel Hudson
Favorite
Hughes, Jasmine
InsightRX
(
M-048
)
mipdtrial: an open-source R package for simulating model-informed precision dosing trials
Jasmine Hughes
Favorite
Hu, Hongxiang
BMS
(
W-043
)
Early sBCMA Kinetics as a Potential Indicator of Progression-Free Survival in Relapsed/Refractory Multiple Myeloma Patients Receiving CAR T-Cell Therapy
Hongxiang Hu
Favorite
(
W-044
)
Population Cellular Kinetics of Orvacabtagene Autoleucel, an Autologous BCMA-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Multiple Myeloma
Hongxiang Hu
Favorite
Hurtado, Felipe
Daiichi Sankyo, Inc.
(
T-064
)
Pharmacokinetic-pharmacodynamic analysis of myelosuppression with raludotatug deruxtecan (R-DXd) in patients with advanced solid tumors
Felipe Hurtado
Favorite
Hynes, Scott
Biogen Inc.
(
T-136
)
Unique Effect of the High-Fat Meal on the Pharmacokinetics of Omaveloxolone Explained by Physiologically Based Biopharmaceutics Modeling
Scott Hynes
Favorite
